
GC14238
Brivanib Alaninate
Also listed as Brivanib Alaninate (BMS-582664)
Brivanib alaninate (BMS-582664) is an ATP-competitive inhibitor against VEGFR2 with an IC50 of 25 nM; has moderate potency against VEGFR-1 and FGFR-1, but more than 240-fold against PDGFRβ
ChemicalCAS649735-63-7MW441.46FormulaC22H24FN5O4
- CAS number
- 649735-63-7
- Molecular weight
- 441.46
- Formula
- C22H24FN5O4
- Solubility
- ≥ 22·05mg/mL in DMSO
- InChIKey
- LTEJRLHKIYCEOX-OCCSQVGLSA-N
- Catalogue number
- GC14238
- Brand
- GLPBIO
Computed properties PubChem CID 11154925 · XLogP 3.1 · TPSA 117 Ų · H-bond donors 2
- XLogP
- 3.1
- TPSA
- 117 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 8
- Heavy atoms
- 32
SMILES CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC(=O)[C@H](C)N)C
Computed descriptors from PubChem (CID 11154925), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il